Rodent models for human diseases.
暂无分享,去创建一个
[1] M. Hoekstra,et al. Mouse models of disturbed HDL metabolism. , 2015, Handbook of experimental pharmacology.
[2] A. Richmond,et al. Mouse xenograft models vs GEM models for human cancer therapeutics , 2008, Disease Models & Mechanisms.
[3] F. Ruddle,et al. Integration and stable germ line transmission of genes injected into mouse pronuclei. , 1981, Science.
[4] Q. Lian,et al. Regulation of 11beta-hydroxysteroid dehydrogenase 1 and 2 by IGF-1 in mice. , 2010, Biochemical and biophysical research communications.
[5] Peter J Houghton,et al. Establishment of human tumor xenografts in immunodeficient mice , 2007, Nature Protocols.
[6] R. Cardiff,et al. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. , 2005, Cancer research.
[7] B. Connolly,et al. Non-Invasive Bioluminescence Imaging of β-Cell Function in Obese-Hyperglycemic [ob/ob] Mice , 2014, PloS one.
[8] Y. Shinoda,et al. Mouse Models of Mutations and Variations in Autism Spectrum Disorder-Associated Genes: Mice Expressing Caps2/Cadps2 Copy Number and Alternative Splicing Variants , 2013, International journal of environmental research and public health.
[9] F. Costantini,et al. Introduction of a rabbit β-globin gene into the mouse germ line , 1981, Nature.
[10] K. Kuo,et al. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[11] F H Ruddle,et al. Genetic transformation of mouse embryos by microinjection of purified DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[12] Markus G. Manz,et al. Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.
[13] M. Kotb,et al. Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.
[14] V. Ntziachristos,et al. Multimodal Molecular Imaging of Integrin αvβ3 for In Vivo Detection of Pancreatic Cancer , 2014, The Journal of Nuclear Medicine.
[15] Zhengxin Wang,et al. Modulation of androgen receptor‐dependent transcription by resveratrol and genistein in prostate cancer cells , 2004, The Prostate.
[16] T. Graeber,et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. , 2003, Cancer cell.
[17] R. Palmiter,et al. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs , 1981, Cell.
[18] R. Jaenisch,et al. Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Cardiff,et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. , 2003, Cancer research.
[20] K. Korach,et al. Estrogen hormone physiology: reproductive findings from estrogen receptor mutant mice. , 2014, Reproductive biology.
[21] Douglas Hanahan,et al. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. , 2007, Genes & development.
[22] M. Capecchi,et al. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.
[23] A. Samarel,et al. Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy. , 2014, Journal of molecular and cellular cardiology.
[24] Todd R. Golub,et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Chambon,et al. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma , 2008, Proceedings of the National Academy of Sciences.
[26] R. Matusik,et al. Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] Wei Chen,et al. Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB/c Mouse Model , 2014, PloS one.
[28] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[29] R. Cardiff,et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. , 2002, Cancer research.
[30] H. Shimokawa,et al. Nitric oxide synthases and heart failure - lessons from genetically manipulated mice. , 2013, Journal of UOEH.
[31] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[32] P. Pandolfi,et al. Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.
[33] M. Sykes,et al. CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway1 , 2001, The Journal of Immunology.
[34] R. Cardiff,et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[36] V. Fendrich,et al. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[37] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Ando,et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. , 2003, Blood.
[39] H. Guillou,et al. P-glycoprotein Dysfunction Contributes to Hepatic Steatosis and Obesity in Mice , 2011, PloS one.
[40] R. Schiestl,et al. IL-13 overexpression in mouse lungs triggers systemic genotoxicity in peripheral blood. , 2014, Mutation research.
[41] K. Kadomatsu,et al. Neuroblastoma models for insights into tumorigenesis and new therapies , 2015, Expert opinion on drug discovery.
[42] C. Sander,et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis , 2009, Nature Genetics.
[43] Pier Paolo Pandolfi,et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate , 2009, Nature Genetics.
[44] L. Chin,et al. BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma , 2008, PloS one.
[45] K. Kretschmer,et al. Foxp3+ Regulatory T Cells in Mouse Models of Type 1 Diabetes , 2013, Journal of diabetes research.
[46] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[47] P. Chaurand,et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. , 2001, Cancer research.
[48] K. Akashi,et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice , 2005 .
[49] Peter A. Humphrey,et al. Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia , 2002, Molecular and Cellular Biology.
[50] Manuel Desco,et al. K-RasV14I recapitulates Noonan syndrome in mice , 2014, Proceedings of the National Academy of Sciences.